European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma
- DOI
- 10.3324/haematol.2016.146977
- Published
- 2016-07-14
- Container
- Haematologica
- Publisher
- Ferrata Storti Foundation (Haematologica)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2016.146977,
title = {European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma},
author = {P. L. Zinzani and L. Karlin and J. Radford and D. Caballero and P. Fields and M. E. D. Chamuleau and F. dAmore and C. Haioun and C. Thieblemont and E. Gonzalez-Barca and C. G. Garcia and P. W. Johnson and G. W. van Imhoff and T. Ng and K. Dwyer and F. Morschhauser},
year = {2016},
journal = {Haematologica},
doi = {10.3324/haematol.2016.146977},
url = {https://doi.org/10.3324/haematol.2016.146977}
}RIS
TY - JOUR TI - European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma AU - P. L. Zinzani AU - L. Karlin AU - J. Radford AU - D. Caballero AU - P. Fields AU - M. E. D. Chamuleau AU - F. dAmore AU - C. Haioun AU - C. Thieblemont AU - E. Gonzalez-Barca AU - C. G. Garcia AU - P. W. Johnson AU - G. W. van Imhoff AU - T. Ng AU - K. Dwyer AU - F. Morschhauser PY - 2016 JO - Haematologica DO - 10.3324/haematol.2016.146977 UR - https://doi.org/10.3324/haematol.2016.146977 ER -
APA
Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., dAmore, F., Haioun, C., Thieblemont, C., Gonzalez-Barca, E., Garcia, C. G., Johnson, P. W., Imhoff, G. W. V., Ng, T., Dwyer, K., & Morschhauser, F. (2016). European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica. https://doi.org/10.3324/haematol.2016.146977
Source records
- crossref · retrieved 2026-09-26T23:13:38.145Z